Skip to main content
Premium Trial:

Request an Annual Quote

Warnex Buys Thermo Fisher Mass Specs for Services Business

NEW YORK (GenomeWeb News) – Quebec, Canada-based Warnex said today that its Bioanalytical Services division has purchased two TSQ Vantage mass spectrometers from Thermo Fisher Scientific, which it will use in its drug research services offerings.
 
Warnex President and CEO Mark Busgang said in a statement that the firm is the first clinical research organization in Canada to acquire the new TSQ Vantage system. “The increased sensitivity of this new generation of systems will allow us to detect our customers’ compounds at very low quantitation levels with great precision,” he said.
 
Warnex said that the TSQ Vantage system provides 10 times more sensitivity than other triple quadrupole instruments on the market.
 
Terms of the purchase were not disclosed.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.